We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Technology 2.7%
3 Consumer Discretionary 1.66%
4 Financials 1.18%
5 Communication Services 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGRE
11051
CALL
DELISTED
Paramount Group
PGRE
$80.6K ﹤0.01%
18,200
-133,100
-88% -$592K
EGHT icon
11052
PUT
8x8 Inc
EGHT
$290M
$80.4K ﹤0.01%
19,000
-44,300
-70% -$160K
PRPH
11053
DELISTED
ProPhase Labs
PRPH
$80K ﹤0.01%
1,101
-2,726
-71% -$222K
HLLY icon
11054
Holley
HLLY
$360M
$79.9K ﹤0.01%
19,535
-2,422
-11% -$7.22K
ILLM
11055
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$79.6K ﹤0.01%
+47,109
New +$75.5K
GNSS icon
11056
CALL
Genasys
GNSS
$70.6M
$79.6K ﹤0.01%
30,600
-1,400
-4% -$3.86K
GRTX
11057
PUT
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$79.2K ﹤0.01%
25,400
+14,200
+127% +$42.2K
CMAX
11058
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$79.1K ﹤0.01%
848
-264
-24% -$23.3K
OIA icon
11059
Invesco Municipal Income Opportunities Trust
OIA
$290M
$78.9K ﹤0.01%
12,652
-9,035
-42% -$56.2K
IDR icon
11060
Idaho Strategic Resources
IDR
$535M
$78.6K ﹤0.01%
14,724
-18,292
-55% -$97K
EDTK icon
11061
Skillful Craftsman
EDTK
$14.6M
$78.6K ﹤0.01%
56,969
+35,406
+164% +$58.3K
ABSI icon
11062
PUT
Absci
ABSI
$1.62B
$78.4K ﹤0.01%
51,600
-65,400
-56% -$105K
DNTH icon
11063
Dianthus Therapeutics
DNTH
$6.24B
$78.3K ﹤0.01%
6,456
-4,888
-43% -$55.6K
CKPT
11064
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$78.3K ﹤0.01%
31,700
+6,700
+27% +$18.3K
AAME icon
11065
Atlantic American Corp
AAME
$32M
$78.3K ﹤0.01%
40,569
+1,296
+3% +$2.88K
PANL icon
11066
Pangaea Logistics
PANL
$517M
$78.2K ﹤0.01%
11,548
-152,719
-93% -$943K
DZZ icon
11067
DB Gold Double Short ETN due Feb 15 2038
DZZ
$2.97M
$78.1K ﹤0.01%
30,495
-2,142
-7% -$5.11K
CLSD
11068
PUT
DELISTED
Clearside Biomedical
CLSD
$78.1K ﹤0.01%
4,647
+567
+14% +$9.76K
FEI
11069
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$77.9K ﹤0.01%
+10,107
New +$77.1K
GROY icon
11070
CALL
Gold Royalty Corp
GROY
$795M
$77.9K ﹤0.01%
44,000
-43,000
-49% -$88.9K
TLYS icon
11071
Tilly's
TLYS
$117M
$77.8K ﹤0.01%
11,094
-4,077
-27% -$29.9K
RBBN icon
11072
PUT
Ribbon Communications
RBBN
$358M
$77.3K ﹤0.01%
+27,700
New +$76.9K
NCZ
11073
Virtus Convertible & Income Fund II
NCZ
$298M
$77.3K ﹤0.01%
6,211
-6,872
-53% -$81.6K
GATO
11074
CALL
DELISTED
Gatos Silver, Inc.
GATO
$77.1K ﹤0.01%
20,400
-25,800
-56% -$139K
TNYA icon
11075
CALL
Tenaya Therapeutics
TNYA
$156M
$76.9K ﹤0.01%
+13,100
New +$76.1K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.